Literature DB >> 16187893

West Nile virus infection among health-fair participants, Wyoming 2003: assessment of symptoms and risk factors.

Tracy D Murphy1, Joe Grandpre, Sandra L Novick, Scott A Seys, Richard W Harris, Karl Musgrave.   

Abstract

Wyoming experienced heavy West Nile virus (WNV) activity for the first time in 2003 and the area hardest hit was Goshen County. Little was known about the epidemiology of WNV in this region. This study describes the symptomatology of WNV and the association between certain behaviors and infection in Goshen County. Study participants were recruited from attendees of a health-fair sponsored by a local hospital, held October 1-3, 2003. A blood sample for WNV testing was obtained from each participant, and participants completed a questionnaire seeking information about the presence of specified symptoms consistent with WNV infection and risk factors possibly associated with infection. The samples were tested for anti-WNV IgM and IgG at the Wyoming Public Health Laboratory. Eight-hundred sixty-nine residents of Goshen County participated, and 122 (14.0%) were seropositive for anti-WNV IgM or IgG. Sixty (59.4%) of 101 persons seropositive for anti-WNV IgM experienced at least one symptom in the previous 4 months consistent with WNV infection, compared with 323 (43.2%) of 747 seronegative persons, resulting in an attributable risk of WNV seropositivity of 16.2%. Of the many symptoms queried, muscle aches (OR 2.63, 95% CI 1.69-4.09), skin rash (OR 6.35, 95% CI 3.74-10.80), fever (OR 2.56, 95% Cl 1.50-4.36), and muscle weakness (OR 2.33, 95% CI 1.34-4.02) were significantly associated with seropositivity on univariate analysis. By multivariate analysis, only skin rash remained significant. Risk factor analysis showed those spending > or =3 hours outside per day were more likely to be seropositive than those spending less time outside per day ( p < 0.05). This study corroborates the belief that a minority of persons infected with WNV develop symptoms attributable to WNV, and also demonstrates that some symptoms are more significantly associated with infection than others.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16187893     DOI: 10.1089/vbz.2005.5.246

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  12 in total

1.  Tissue expression of steroid hormone receptors is associated with differential immune responsiveness.

Authors:  Cherié L Butts; Yava L Jones; Jean K Lim; Caroline E Salter; Elena Belyavskaya; Esther M Sternberg
Journal:  Brain Behav Immun       Date:  2010-11-11       Impact factor: 7.217

2.  Demographic and clinical factors associated with persistent symptoms after West Nile virus infection.

Authors:  Robert L Cook; Xiaohui Xu; Eric J Yablonsky; Nikole Sakata; Jennifer H Tripp; Rachel Hess; Paolo Piazza; Charles R Rinaldo
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

3.  Drought and immunity determine the intensity of West Nile virus epidemics and climate change impacts.

Authors:  Sara H Paull; Daniel E Horton; Moetasim Ashfaq; Deeksha Rastogi; Laura D Kramer; Noah S Diffenbaugh; A Marm Kilpatrick
Journal:  Proc Biol Sci       Date:  2017-02-08       Impact factor: 5.349

Review 4.  Risk factors for West Nile virus infection and disease in populations and individuals.

Authors:  Ruth R Montgomery; Kristy O Murray
Journal:  Expert Rev Anti Infect Ther       Date:  2015-01-30       Impact factor: 5.091

5.  Lack of evidence of increased West Nile virus disease severity in the United States in 2012.

Authors:  Nicole P Lindsey; J Erin Staples; Mark J Delorey; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2013-11-11       Impact factor: 2.345

6.  Serologic surveillance for West Nile virus and other flaviviruses in febrile patients, encephalitic patients, and asymptomatic blood donors in northern Mexico.

Authors:  María de Lourdes Garza Rodríguez; Diana R Rodríguez Rodriguez; Bradley J Blitvich; Miguel A Reyes López; Ildefonso Fernández-Salas; Javier Ramos Jimenez; José A Farfán-Ale; Rogelio Cazares Tamez; César Martinez Longoria; Maria I Tavitas Aguilar; Ana Maria Rivas-Estilla
Journal:  Vector Borne Zoonotic Dis       Date:  2010-03       Impact factor: 2.133

7.  Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic.

Authors:  Beth K Schweitzer; Wayne L Kramer; Anthony R Sambol; Jane L Meza; Steven H Hinrichs; Peter C Iwen
Journal:  Clin Vaccine Immunol       Date:  2006-03

8.  Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008.

Authors:  Paul J Carson; Stephanie M Borchardt; Brian Custer; Harry E Prince; Joan Dunn-Williams; Valerie Winkelman; Leslie Tobler; Brad J Biggerstaff; Robert Lanciotti; Lyle R Petersen; Michael P Busch
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

9.  West Nile virus infection among the homeless, Houston, Texas.

Authors:  Tamra E Meyer; Lara M Bull; Kelly Cain Holmes; Rhia F Pascua; Amelia Travassos da Rosa; Christian R Gutierrez; Tracie Corbin; Jennifer L Woodward; Jeffrey P Taylor; Robert B Tesh; Kristy O Murray
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

10.  West Nile virus infection in plasma of blood and plasma donors, United States.

Authors:  Christina B Planitzer; Jens Modrof; Mei-ying W Yu; Thomas R Kreil
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.